Medicare Enrolled
Dr. Saumil Oza, M.D.
Cardiovascular Disease · Jacksonville, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Oza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oza? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oza
Dr. Saumil Oza is a cardiovascular disease in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Oza performed 7,981 Medicare services across 4,235 unique beneficiaries.
Between the years covered by Open Payments, Dr. Oza received a total of $320,323 from 44 pharmaceutical and/or device companies across 683 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 10% volume in FL$ $320,323 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,981
Medicare services
Top 10% in FL for cardiovascular disease
4,235
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~420 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days | 926 | $15 | $77 |
| Electrocardiogram (EKG), 12-lead | 839 | $11 | $51 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 777 | $26 | $104 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 701 | $19 | $83 |
| Remote pacemaker monitoring, 90 days | 634 | $21 | $104 |
| Office visit, established patient (30-39 min) | 628 | $93 | $323 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 404 | $18 | $74 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 325 | $9 | $44 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 324 | $18 | $86 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 298 | $27 | $207 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 196 | $255 | $1,381 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 192 | $255 | $1,384 |
| Office visit, established patient, complex (40-54 min) | 192 | $132 | $436 |
| Programming of dual lead pacemaker system | 185 | $57 | $175 |
| Programming of heart rhythm stimulation after drug infusion | 184 | $66 | $515 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 167 | $788 | $3,649 |
| Prothrombin time test (blood clotting) | 154 | $4 | $16 |
| New patient office visit, complex (60-74 min) | 104 | $168 | $627 |
| Programming of multiple lead implantable defibrillator system | 78 | $72 | $271 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 72 | $19 | $81 |
| External shock to heart to regulate heart beat | 66 | $86 | $477 |
| Programming of dual lead implantable defibrillator system | 62 | $69 | $244 |
| Repair of left upper heart chamber with implant with review by radiologist | 60 | $651 | $2,583 |
| Heart rhythm recording of continous external ekg over 8-15 days | 56 | $9 | $44 |
| Telephone medical discussion with physician, 11-20 minutes | 54 | $65 | $220 |
| Programming of multiple lead pacemaker system | 44 | $59 | $206 |
| New patient office visit (45-59 min) | 41 | $110 | $497 |
| Initial hospital admission, moderate complexity | 32 | $105 | $419 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 31 | $7 | $28 |
| Hospital follow-up visit, moderate complexity | 29 | $60 | $220 |
| Office visit, established patient (20-29 min) | 25 | $66 | $220 |
| Hospital follow-up visit, high complexity | 18 | $96 | $319 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $95 | $243 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $696 | $2,716 |
| Evaluation of cardiac rhythm monitor system | 14 | $39 | $110 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 14 | $846 | $3,637 |
| Electrocardiogram (ecg) 2-day continuous | 13 | $13 | $78 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 11 | $58 | $438 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
35.5% high complexity
0.1% medium
64.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$320,323
Total received (2018-2024)
Avg $45,760/year across 7 years
Top 1% in FL for cardiovascular disease
44
Companies
683
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$228,276 (71.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$77,926 (24.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,121 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$138,446
2023$85,649
2022$49,531
2021$11,295
2020$5,160
2019$13,955
2018$16,287
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medical Device Business Services, Inc.
$81,749
Boston Scientific Corporation
$76,566
Biosense Webster, Inc.
$68,693
Volta Medical Inc
$44,722
ATRICURE, INC.
$19,802
E.R. Squibb & Sons, L.L.C.
$4,299
GE HEALTHCARE
$4,186
AtriCure, Inc.
$3,782
ABIOMED
$3,666
Novo Nordisk Inc
$3,395
AltaThera Pharmaceuticals LLC
$3,022
Abbott Laboratories
$1,384
Medtronic Vascular, Inc.
$754
Acutus Medical, Inc.
$480
iRhythm Technologies, Inc.
$393
BOSTON SCIENTIFIC CORPORATION
$380
Edwards Lifesciences Corporation
$366
Janssen Pharmaceuticals, Inc
$342
CardioFocus, Inc.
$224
Novartis Pharmaceuticals Corporation
$211
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$207
Cortex, Inc.
$199
Medtronic, Inc.
$153
Haemonetics Corporation
$150
CARDIVA MEDICAL, INC.
$145
Johnson & Johnson Health Care Systems Inc.
$121
Philips Electronics North America Corporation
$119
MicroPort CRM USA Inc
$108
ShockWave Medical, Inc
$105
PFIZER INC.
$96
AstraZeneca Pharmaceuticals LP
$92
SANOFI-AVENTIS U.S. LLC
$83
Braemar Manufacturing, LLC
$51
Gilead Sciences, Inc.
$49
Amgen Inc.
$38
Bardy Diagnostics, Inc.
$30
HeartFlow, Inc.
$28
Zimmer Biomet Holdings, Inc.
$22
Octapharma USA, Inc.
$21
Regeneron Healthcare Solutions, Inc.
$21
Aziyo Biologics, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Amarin Pharma Inc.
$18
DAVOL INC.
$13
Top 3 companies account for 70.9% of total payments
Associated products mentioned in payments ›
(5050) Ext Holter · (9314) Kodex System · ABSOLUTE PRO · ACCOLADE SR · AMPLATZER · AMPLATZER AMULET · ARCTIC FRONT ADVANCE · ARISTA AH · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · ATRICURE SYNERGY ABLATION SYSTEM · Advisa · Allia · Amplia MRI · Arctic Front · Azure · BRILINTA · BYDUREON · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CRM Product · Cardiac Monitoring Suite · CardioLab · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · CartoSound · Cobalt · Confirm Rx · ECM Patch · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · EPD KODEX Innovation · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ensite Cardiac Mapping System · FARXIGA · FFRct · GENERAL TACHY · GENERAL - THERAPIES · GENERAL TACHY · General - Therapies · General - Vascular Intervention · HEARTLIGHT SYSTEM · HeartLight System · INOGEN · Impella · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MODELS · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NA · NUVISION ICE CATHETER · Navistar · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OCTARAY MAPPING CATHETER · PENTARAY · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pentaray · Perclose ProGlide suture mediated closure system · Pouch · Proclaim Family of SCS IPGs · QDOT MICRO Catheter · REMICADE · RESONATE · RESONATE EL ICD VR · RHYTHMIA · Repatha · Rhythmia Mapping System · SENSOR ENABLED · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY ABLATION SYSTEM · Sotalol Hydrochloride · TACTICATH ABLATION CATHETER · TEG6s HEMOSTASIS SYSTEM · VIGILANT · VISCO-3 · VX1 · Vascepa · Visitag · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (71%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for cardiovascular disease in FL.
Equivalent to $4,014 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
155
Per 100K population
15.4
County median income
$68,447
Nearest hospital
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Oza is a remote & electrophysiology specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (consulting-driven, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Oza experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Oza performed 926 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oza receive payments from pharmaceutical companies?
Yes. Dr. Oza received a total of $320,323 from 44 companies across 683 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oza's costs compare to other cardiovascular diseases in Jacksonville?
Dr. Oza's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Jacksonville
Browse cardiovascular diseases in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology